13F filer · CIK 1422849 ↗
Capital World Investors
You are looking at Q4 2022. See the latest, Q2 2026 →
Reported value
$469.11B
+5.3% on the quarter before
Positions
539
26 new · 36 sold out
Top 10
26.3%
of the value
Est. gain
+$37.04B
on stocks held all quarter
Est. return
+9.3%
on those stocks since Q3 2022
Positions as of Dec 31, 2022, from Capital World Investors's 13F filing with the SEC. A 13F lists a manager's US-listed stocks and options at a quarter end and is filed up to 45 days later, so the fund may hold something else today. It leaves out short positions, cash and holdings outside the US.
Portfolio at a glance
- New
- Added
- Cut
- Same
- Options
The 24 largest positions, 41% of the reported value, each sized by its share, colored by what the fund did with it since Q3 2022. Striped tiles are options.
Largest buys
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Target Corp~$2.15BAdded · 0.6% → 1.0%+14,453,675 shares
- Jpmorgan Chase & Co~$1.89BAdded · 0.9% → 1.5%+14,077,797 shares
- Goldman Sachs~$1.66BAdded · 0.1% → 0.4%+4,827,674 shares
- Philip Morris Intl Inc~$1.50BAdded · 1.6% → 2.2%+14,789,976 shares
- Blackstone Inc~$1.01BAdded · 0.3% → 0.5%+13,587,310 shares
- Gilead Sciences Inc~$955.5MAdded · 0.8% → 1.3%+11,130,228 shares
- Lennar Corp~$784.5MAdded · 0.3% → 0.5%+8,668,319 shares
- Morgan Stanley~$746.2MAdded · 0.3% → 0.5%+8,776,196 shares
- Canadian Nat Res Ltd~$599.4MAdded · 1.5% → 1.8%+10,793,731 shares
- Brookfield Corp~$594.6MNew · 0.0% → 0.1%+18,901,023 shares
Largest sells
Since Q3 2022, by estimated size: the change in shares at the quarter-end price, since a 13F gives no trade prices. Percentages are the position's share of the portfolio, before and after.
- Tesla~$5.14BCut · 5.4% → 1.3%−41,730,452 shares
- Cme Group Inc~$2.62BCut · 1.2% → 0.6%−15,554,066 shares
- Microsoft~$1.39BCut · 5.1% → 4.7%−5,813,934 shares
- Unitedhealth Group Inc~$1.34BCut · 3.8% → 3.5%−2,535,566 shares
- Verizon Communications Inc~$1.33BCut · 0.4% → 0.1%−33,629,891 shares
- Broadcom~$1.26BCut · 3.2% → 3.5%−2,252,738 shares
- Activision Blizzard Inc~$1.23BCut · 0.4% → 0.1%−16,021,629 shares
- Alphabet~$1.06BCut · 1.3% → 0.9%−12,001,863 shares
- Amazon~$986.7MCut · 0.7% → 0.3%−11,746,695 shares
- M & T Bk Corp~$896.3MCut · 0.3% → 0.0%−6,179,135 shares
Holdings
As of Dec 31, 2022. Changes are in shares against Sep 30, 2022, so a price move alone never reads as a buy or a sale.
| Holding | Value | ||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| MicrosoftCOM · shares −6.0% · price +3.0% | 4.7% | $22.00B | +$634.2M | ||||||||
| BroadcomCOM · shares −7.1% · price +25.9% | 3.5% | $16.42B | +$3.38B | ||||||||
| Unitedhealth Group IncCOM · shares −7.6% · price +5.0% | 3.5% | $16.27B | +$771.4M | ||||||||
| Pfizer IncCOM · shares +2.9% · price +17.1% | 2.8% | $13.12B | +$1.86B | ||||||||
| Home Depot IncCOM · shares −2.2% · price +14.5% | 2.6% | $12.37B | +$1.56B | ||||||||
| Eli LillyCOM · shares −2.9% · price +13.1% | 2.2% | $10.31B | +$1.20B | ||||||||
| Philip Morris Intl IncCOM · shares +17% · price +21.9% | 2.2% | $10.09B | +$1.54B | ||||||||
| Canadian Nat Res LtdCOM · shares +7.7% · price +19.3% | 1.8% | $8.38B | +$1.26B | ||||||||
| Thermo Fisher Scientific IncCOM · shares +0.4% · price +8.6% | 1.6% | $7.46B | +$586.7M | ||||||||
| Jpmorgan Chase & CoCOM · shares +36% · price +28.3% | 1.5% | $7.12B | +$1.15B | ||||||||
| Caterpillar IncCOM · shares +0.1% · price +46.0% | 1.5% | $6.97B | +$2.19B | ||||||||
| TeslaCOM · shares −46% · price −53.6% | 1.3% | $5.97B | −$6.88B | ||||||||
| Gilead Sciences IncCOM · shares +19% · price +39.2% | 1.3% | $5.91B | +$1.40B | ||||||||
| Lockheed Martin CorpCOM · shares −12% · price +25.9% | 1.1% | $5.29B | +$1.09B | ||||||||
| Cvs Health CorpCOM · shares −7.2% · price −2.3% | 1.1% | $5.27B | −$123.4M | ||||||||
| Target CorpCOM · shares +83% · price +0.4% | 1.0% | $4.74B | +$11.2M | ||||||||
| Regeneron PharmaceuticalsCOM · shares +0.3% · price +4.7% | 0.96% | $4.50B | +$203.1M | ||||||||
| Pioneer Nat Res CoCOM · shares −0.2% · price +5.5% | 0.93% | $4.36B | +$226.4M | ||||||||
| AlphabetCAP STK CL C · shares −20% · price −7.7% | 0.90% | $4.22B | −$353.2M | ||||||||
| Linde PlcSHS · shares +3.0% · price +20.9% | 0.88% | $4.14B | +$695.3M | ||||||||
| Centene Corp DelCOM · shares +2.3% · price +5.4% | 0.87% | $4.08B | +$204.4M | ||||||||
| Alnylam Pharmaceuticals IncCOM · shares +17% · price +18.7% | 0.83% | $3.90B | +$522.9M | ||||||||
| AppleCOM · shares −0.6% · price −6.0% | 0.82% | $3.84B | −$244.9M | ||||||||
| Archer Daniels Midland CoCOM · shares −3.8% · price +15.4% | 0.80% | $3.75B | +$501.2M | ||||||||
| Booking Holdings IncCOM · shares +4.3% · price +22.6% | 0.80% | $3.75B | +$663.2M | ||||||||
| Total · 539 positions | 100% | $469.11B | +$37.04B |
Price is a stock's reported value over its shares at the quarter end. The estimated gain is the shares held at both quarter ends times the change in that price: shares bought or sold during the quarter add nothing, options are left out, and a stock split is read into the earlier share count and price.
What made money
From Q3 2022 to Q4 2022: 507 stocks held throughout, up $37.04B (+9.3%).
- Broadcom+$3.38B+26%
- Caterpillar Inc+$2.19B+46%
- Pfizer Inc+$1.86B+17%
- Home Depot Inc+$1.56B+14%
- Philip Morris Intl Inc+$1.54B+22%
- Catalent Inc−$312.0M−38%
- Alphabet−$353.2M−8%
- Meta−$465.4M−11%
- Amazon−$515.8M−26%
- Tesla−$6.88B−54%
Estimated as in the holdings table: shares held at both quarter ends times the change in price; options left out, 1 split read into the share counts.
Reported value by quarter
The total value of each quarter's 13F at that quarter end. It moves with prices as well as with buying and selling. Pick a quarter to see what the fund held then.
Every quarter's filing
| Quarter | Reported value | Filing | |
|---|---|---|---|
| Q2 2026 | Aug 12, 2026 | $846.43B+15% | SEC ↗ |
| Q1 2026 | May 13, 2026 | $732.94B−0% | SEC ↗ |
| Q4 2025 | Feb 11, 2026 | $735.30B+0% | SEC ↗ |
| Q3 2025 | Nov 13, 2025 | $732.04B+6% | SEC ↗ |
| Q2 2025 | Aug 13, 2025 | $687.95B+11% | SEC ↗ |
| Q1 2025 | May 12, 2025 | $617.20B−6% | SEC ↗ |
| Q4 2024 | Feb 13, 2025 | $658.71B+2% | SEC ↗ |
| Q3 2024 | Nov 13, 2024 | $645.05B+5% | SEC ↗ |
| Q2 2024 | Aug 13, 2024 | $613.27B+1% | SEC ↗ |
| Q1 2024 | May 14, 2024 | $604.23B+7% | SEC ↗ |
| Q4 2023 | Feb 13, 2024 | $562.26B+11% | SEC ↗ |
| Q3 2023 | Nov 13, 2023 | $504.81B−3% | SEC ↗ |
| Q2 2023 | Aug 11, 2023 | $519.91B+7% | SEC ↗ |
| Q1 2023 | May 15, 2023 | $483.79B+3% | SEC ↗ |
| Q4 2022 | Feb 14, 2023 | $469.11B+5% | SEC ↗ |
| Q3 2022 | Nov 14, 2022 | $445.41B−5% | SEC ↗ |
| Q2 2022 | Aug 15, 2022 | $470.72B−19% | SEC ↗ |
| Q1 2022 | May 19, 2022 (amended) | $580.76B−8% | SEC ↗ |
| Q4 2021 | Feb 14, 2022 | $632.21B+8% | SEC ↗ |
| Q3 2021 | Nov 15, 2021 | $585.85B−0% | SEC ↗ |
| Q2 2021 | Aug 16, 2021 | $588.43B+9% | SEC ↗ |
| Q1 2021 | May 14, 2021 | $541.07B+4% | SEC ↗ |
| Q4 2020 | Feb 12, 2021 | $518.94B+14% | SEC ↗ |
| Q3 2020 | Nov 13, 2020 | $456.91B+11% | SEC ↗ |
| Q2 2020 | Aug 14, 2020 | $413.27B+20% | SEC ↗ |
| Q1 2020 | May 15, 2020 | $344.62B−23% | SEC ↗ |
| Q4 2019 | Feb 18, 2020 | $447.39B+8% | SEC ↗ |
| Q3 2019 | Nov 14, 2019 | $415.21B−3% | SEC ↗ |
| Q2 2019 | Aug 14, 2019 | $426.29B+3% | SEC ↗ |
| Q1 2019 | May 15, 2019 | $412.39B+12% | SEC ↗ |
| Q4 2018 | Feb 14, 2019 | $369.11B−10% | SEC ↗ |
| Q3 2018 | Nov 14, 2018 | $411.05B−12% | SEC ↗ |
| Q2 2018 | Aug 14, 2018 | $467.29B+5% | SEC ↗ |
| Q1 2018 | May 15, 2018 | $444.21B−4% | SEC ↗ |
| Q4 2017 | Feb 14, 2018 | $461.25B+4% | SEC ↗ |
| Q3 2017 | Nov 14, 2017 | $441.49B+4% | SEC ↗ |
| Q2 2017 | Aug 14, 2017 | $425.76B+2% | SEC ↗ |
| Q1 2017 | May 15, 2017 | $418.31B+5% | SEC ↗ |
| Q4 2016 | Feb 15, 2017 | $397.60B+3% | SEC ↗ |
| Q3 2016 | Nov 14, 2016 | $384.55B+4% | SEC ↗ |
| Q2 2016 | Aug 15, 2016 | $370.85B+2% | SEC ↗ |
| Q1 2016 | May 16, 2016 | $361.93B | SEC ↗ |